|
|
| (11) | Number of the document | C 1667986 |
| (68) | Number of the document | 1667986 |
| (21) | Application number for Supplementary Protection Certificate | PA 2013 010 |
| (22) | Date of filing the application | 2013-05-15 |
| (41) | Date of publication of the application | 2013-06-25 |
| Date of publication of SPC | 2014-01-27 | |
| (24) | Date of coming into effect of SPC | 2024-09-17 |
| (71) |
Aventis Pharma S.A.,
20, avenue Raymond Aron, 92160 Antony,
FR
|
| (73) |
Aventis Pharma S.A.,
20, avenue Raymond Aron, 92160 Antony,
FR
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/11/676/001, 2011-03-17 |
| (94) | 2026-03-22 |
| (95) | Cabazitaxelum |
| SPC lapsed (non-payment of fees for the main patent) | ||
| Date of negative decision to issue the SPC | 2022-09-16 |